Biodesix Inc (NASDAQ: BDSX) open the trading on Wednesday, with a bit cautious approach as it glided -1.86% to $1.58, before settling in for the price of $1.61 at the close. Taking a more long-term approach, BDSX posted a 52-week range of $1.15-$2.21.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 24.79%. Meanwhile, its Annual Earning per share during the time was 8.42%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 45.31%. This publicly-traded company’s shares outstanding now amounts to $96.24 million, simultaneously with a float of $76.49 million. The organization now has a market capitalization sitting at $229.38 million. At the time of writing, stock’s 50-day Moving Average stood at $1.7416, while the 200-day Moving Average is $1.6150.
Biodesix Inc (BDSX) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Diagnostics & Research industry. Biodesix Inc’s current insider ownership accounts for 47.31%, in contrast to 36.81% institutional ownership. According to the most recent insider trade that took place on Aug 09 ’24, this organization’s Chief Accounting Officer sold 155 shares at the rate of 1.60, making the entire transaction reach 248 in total value, affecting insider ownership by 11,242. Preceding that transaction, on Aug 12 ’24, Company’s Chief Accounting Officer sold 54 for 1.57, making the whole transaction’s value amount to 85. This particular insider is now the holder of 11,188 in total.
Biodesix Inc (BDSX) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
Biodesix Inc’s EPS increase for this current 12-month fiscal period is 45.31% and is forecasted to reach -0.22 in the upcoming year.
Biodesix Inc (NASDAQ: BDSX) Trading Performance Indicators
Let’s observe the current performance indicators for Biodesix Inc (BDSX). It’s Quick Ratio in the last reported quarter now stands at 3.21. The Stock has managed to achieve an average true range (ATR) of 0.08. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 3.77.
In the same vein, BDSX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.46, a figure that is expected to reach -0.07 in the next quarter, and analysts are predicting that it will be -0.22 at the market close of one year from today.
Technical Analysis of Biodesix Inc (BDSX)
[Biodesix Inc, BDSX] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 25.98% While, its Average True Range was 0.0793.
Raw Stochastic average of Biodesix Inc (BDSX) in the period of the previous 100 days is set at 45.24%, which indicates a major rise in contrast to 15.01% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 33.48% that was lower than 49.83% volatility it exhibited in the past 100-days period.
